These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 16298551)

  • 1. The etiology of sepsis: turned inside out.
    Brunn GJ; Platt JL
    Trends Mol Med; 2006 Jan; 12(1):10-6. PubMed ID: 16298551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toward a modern concept of sepsis: new answers to ancient questions.
    Brunn GJ; Wijdicks MF; Platt JL
    Discov Med; 2006 Feb; 6(31):11-7. PubMed ID: 17234122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sepsis: avoiding its deadly toll.
    Decker T
    J Clin Invest; 2004 May; 113(10):1387-9. PubMed ID: 15146235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toll-like receptor-4 antagonist eritoran tetrasodium for severe sepsis.
    Tidswell M; LaRosa SP
    Expert Rev Anti Infect Ther; 2011 May; 9(5):507-20. PubMed ID: 21609262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TLR signaling pathway in patients with sepsis.
    Salomão R; Martins PS; Brunialti MK; Fernandes Mda L; Martos LS; Mendes ME; Gomes NE; Rigato O
    Shock; 2008 Oct; 30 Suppl 1():73-7. PubMed ID: 18704004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The innate immune system and its relevance to neonatal sepsis.
    Kenzel S; Henneke P
    Curr Opin Infect Dis; 2006 Jun; 19(3):264-70. PubMed ID: 16645488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toll-like receptor 4 signal transduction inhibitor, M62812, suppresses endothelial cell and leukocyte activation and prevents lethal septic shock in mice.
    Nakamura M; Shimizu Y; Sato Y; Miyazaki Y; Satoh T; Mizuno M; Kato Y; Hosaka Y; Furusako S
    Eur J Pharmacol; 2007 Aug; 569(3):237-43. PubMed ID: 17588563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pivotal advance: endogenous pathway to SIRS, sepsis, and related conditions.
    Tang AH; Brunn GJ; Cascalho M; Platt JL
    J Leukoc Biol; 2007 Aug; 82(2):282-5. PubMed ID: 17495051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sepsis since the discovery of Toll-like receptors: disease concepts and therapeutic opportunities.
    Leaver SK; Finney SJ; Burke-Gaffney A; Evans TW
    Crit Care Med; 2007 May; 35(5):1404-10. PubMed ID: 17414083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toll-like receptor 4 plays a role in macrophage phagocytosis during peritoneal sepsis.
    Anand RJ; Kohler JW; Cavallo JA; Li J; Dubowski T; Hackam DJ
    J Pediatr Surg; 2007 Jun; 42(6):927-32; discussion 933. PubMed ID: 17560196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Toll-like receptors and their role in regulation of the inflammatory response in sepsis].
    Krawczyk-Michalak K; Glapiński A; Brzezińska-Błaszczyk E
    Anestezjol Intens Ter; 2008; 40(4):253-59. PubMed ID: 19517667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathways of renal injury in systemic gram-negative sepsis.
    El-Achkar TM; Hosein M; Dagher PC
    Eur J Clin Invest; 2008 Oct; 38 Suppl 2():39-44. PubMed ID: 18826480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stress molecules in sepsis and systemic inflammatory response syndrome.
    Adib-Conquy M; Cavaillon JM
    FEBS Lett; 2007 Jul; 581(19):3723-33. PubMed ID: 17428476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compartmentalization of the inflammatory response in sepsis and SIRS.
    Cavaillon JM; Annane D
    J Endotoxin Res; 2006; 12(3):151-70. PubMed ID: 16719987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The inflammatory caspases: guardians against infections and sepsis.
    Scott AM; Saleh M
    Cell Death Differ; 2007 Jan; 14(1):23-31. PubMed ID: 16977333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toll-like receptor 4 agonists adsorbed to aluminium hydroxide adjuvant attenuate ovalbumin-specific allergic airway disease: role of MyD88 adaptor molecule and interleukin-12/interferon-gamma axis.
    Bortolatto J; Borducchi E; Rodriguez D; Keller AC; Faquim-Mauro E; Bortoluci KR; Mucida D; Gomes E; Christ A; Schnyder-Candrian S; Schnyder B; Ryffel B; Russo M
    Clin Exp Allergy; 2008 Oct; 38(10):1668-79. PubMed ID: 18631348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SIRS and group-B streptococcal sepsis in newborns: pathogenesis and perspectives in adjunctive therapy.
    Henneke P; Berner R
    Semin Fetal Neonatal Med; 2006 Oct; 11(5):333-42. PubMed ID: 16690364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock.
    Vogl T; Tenbrock K; Ludwig S; Leukert N; Ehrhardt C; van Zoelen MA; Nacken W; Foell D; van der Poll T; Sorg C; Roth J
    Nat Med; 2007 Sep; 13(9):1042-9. PubMed ID: 17767165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of ketamine on levels of cytokines, NF-kappaB and TLRs in rat intestine during CLP-induced sepsis.
    Yu M; Shao D; Liu J; Zhu J; Zhang Z; Xu J
    Int Immunopharmacol; 2007 Aug; 7(8):1076-82. PubMed ID: 17570324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Acute phase reaction and immunocompetence in sepsis and SIRS].
    Burdon D; Zabel P
    Wien Klin Wochenschr; 2002; 114 Suppl 1():1-8. PubMed ID: 15503551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.